RPS29P15

Across TCGA pan-cancer cohorts, RPS29P15 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of RPS29P15’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where RPS29P15 RNA is repressed in tumor relative to normal tissue. In most cancer types RPS29P15 is over-expressed in tumor, although a few such as LUSC and LUAD show the opposite, repressed pattern.

LUSC, LUAD, and STAD are the cancer types where RPS29P15 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS29P15 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	All	All	−0.240	<.001	5	view →
LUAD	All	All	−0.158	.009	4	view →
STAD	Female	III,IV	+0.454	.001	3	view →
PAAD	Female	All	−0.500	.045	2	view →
BRCA	All	III,IV	+0.085	.028	2	view →
LIHC	All	II,III,IV	−0.049	.039	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

RPS29P15–LUSC

Open the LUSC breakdown →